Unlocking the Potential
of Biologic Medicine
Harnessing the Biology of Sphingolipids
About Transcera
Transforming Biologic
Medicine Delivery
— 01
The Problem
Absorption and distribution of biologic drug molecules within the body are limited by epithelial and endothelial cell barriers, such as the intestinal mucosa and the blood-brain barrier. Traditional delivery approaches have failed to overcome these obstacles.
— 02
A Solution from Nature
Partner with Us
Oral Biologics
Leveraging transcytosis to enable mucosal absorption of large molecule therapeutics, eliminating the need for injections and improving accessibility.
Amplified Biodistribution
Our fully synthetic lipid vehicles can be tuned to enhance uptake and retention in different tissues, providing a more potent and durable effect.
Intracellular Delivery
Advancing intracellular delivery techniques to ensure precise and effective targeting of therapeutic molecules, promising enhanced treatments for a range of health conditions.
Let's talk about the future of biologic medicine
Meet Our Team
Wayne Lencer, MD
Academic Co-Founder
Hunter Goble, MBA
Co-Founder & CEO
Justin Wolfe, PhD
Co-Founder & CSO
Deepa Patil, PhD
Scientist II
Christina McGuire, PhD
Principal Scientist
Joanna Podkalicka, PhD
Senior Scientist
Jiaqian Li, PhD
Scientist
FUNDED BY
Connect with Us
Whether you’re a potential partner, researcher, or simply intrigued, we invite you to get in touch.
Please fill information below.